The information will also be updated in ParentVue. Bus information for students during Phases 2-4 will be posted in ParentVue. Once all students are able to return to in-person learning, additional features in school locator will be added such as bus assignment, bus stop location, and estimated pick-up and drop-off times.
Nasdaq: Kymera Therapeutics Announces Positive First-in-Human Results from Phase 1 Healthy Volunteer Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader
Complete STAT6 degradation achieved in both blood and skin at all MAD doses ≥50 mg KT-621 impact on Th2 biomarkers in line or superior to dupilumab with median TARC reduction up to 37% and median ...
Kymera Therapeutics Announces Positive First-in-Human Results from Phase 1 Healthy Volunteer Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader
Seeking Alpha: Kymera Therapeutics soars 35% on positive phase 1 results for oral STAT6 degrader KT-621
Kymera Therapeutics (NASDAQ:KYMR) Monday reported positive Phase 1 results from its healthy volunteer study of KT-621, a first-in-class oral STAT6 degrader, sending shares up +35% in premarket trading ...
Kymera Therapeutics soars 35% on positive phase 1 results for oral STAT6 degrader KT-621